OneSource Closes USFDA Inspection Successfully

  Published 1 year ago

USFDA closed the inspection after VAI classification, citing strong compliance and response to Form 483 observations.

  • CEO highlights facility’s role in DDC, biologics, and complex injectables for GLP, 1 launches.
  • The company’s five approved facilities and 1,200+ professionals support specialty pharma manufacturing.
  • Closure validates commitment to quality, advancing the commercial phase with key partners.

You might like these

Bharat Electronics Gains on Missile Deal

Zen Secures Indian Anti‑Drone Contract

TCS Expands 5-Year Deal with Weatherford

Kajaria Q2 FY26 Results: Revenue Up, Margins Rise

Tesla Spain Sales Decline as EV Market Booms

Bajaj Finserv Targets 22% CAGR Growth

Flipkart Gains Lending License in India

News that matters the most ⚡